Q9TUP7
Gene name |
HCRTR2 |
Protein name |
Orexin receptor type 2 |
Names |
Ox-2-R, Ox2-R, Ox2R, Hypocretin receptor type 2 |
Species |
Canis lupus familiaris (Dog) (Canis familiaris) |
KEGG Pathway |
cfa:399545 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9TUP7
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9TUP7-F1 | Predicted | AlphaFoldDB |
1 variants for Q9TUP7
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| 54 | E>K | narcolepsy; autosomal recessive; loss of function [UniProt] | No |
No associated diseases with Q9TUP7
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| G protein-coupled receptor activity | Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. |
| orexin receptor activity | Combining with orexin to initiate a change in cell activity. |
8 GO annotations of biological process
| Name | Definition |
|---|---|
| circadian sleep/wake cycle process | A behavioral process involved in the cycle from wakefulness through an orderly succession of sleep states and stages that occurs on an approximately 24 hour rhythm. |
| feeding behavior | Behavior associated with the intake of food. |
| G protein-coupled receptor signaling pathway | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. |
| locomotion | Self-propelled movement of a cell or organism from one location to another. |
| neuropeptide signaling pathway | A G protein-coupled receptor signaling pathway initiated by a neuropeptide binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process. |
| phospholipase C-activating G protein-coupled receptor signaling pathway | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation of phospholipase C (PLC) and a subsequent increase in the intracellular concentration of inositol trisphosphate (IP3) and diacylglycerol (DAG). |
| regulation of circadian sleep/wake cycle, wakefulness | Any process that modulates the rate, frequency, or extent of the wakeful phase of the circadian sleep/wake cycle. The wakeful phase is the part of the circadian sleep/wake cycle where the organism is not asleep. |
| regulation of cytosolic calcium ion concentration | Any process involved in the maintenance of an internal steady state of calcium ions within the cytosol of a cell or between the cytosol and its surroundings. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MSGTKLEDSP | PCRNWSSAPE | LNETQEPFLN | PTDYDDEEFL | RYLWREYLHP | KEYEWVLIAG |
| 70 | 80 | 90 | 100 | 110 | 120 |
| YIIVFVVALV | GNVLVCVAVW | KNHHMRTVTN | YFIVNLSLAD | VLVTITCLPA | TLVVDITETW |
| 130 | 140 | 150 | 160 | 170 | 180 |
| FFGQSLCKVI | PYLQTVSVSV | SVLTLSCIAL | DRWYAICHPL | MFKSTAKRAR | NSIVIIWIVS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| CIIMIPQAIV | MECSTMLPGL | ANKTTLFTVC | DERWGGEIYP | KMYHICFFLV | TYMAPLCLMV |
| 250 | 260 | 270 | 280 | 290 | 300 |
| LAYLQIFRKL | WCRQIPGTSS | VVQRKWKPLQ | PASQPRGPGQ | QTKSRISAVA | AEIKQIRARR |
| 310 | 320 | 330 | 340 | 350 | 360 |
| KTARMLMVVL | LVFAICYLPI | SILNVLKRVF | GMFTHTEDRE | TVYAWFTFSH | WLVYANSAAN |
| 370 | 380 | 390 | 400 | 410 | 420 |
| PIIYNFLSGK | FREEFKAAFS | CCCLGVHHRQ | EDRLTRGRTS | TESRKSLTTQ | ISNFDNVSKL |
| 430 | 440 | ||||
| SEQVVLTSIS | TLPAANGAGP | LQNW |